Percutaneous aortic valve implantation;Implantação da válvula aórtica por via percûtanea

Revista Portuguesa de Cardiologia

Volumn 29, Issue 11, 2010, Pages 1699-1712

  Caeiro, Daniel ^a   Fontes Carvalho, R ^a   Lima, Rui ^a   Melica, Bruno ^a   Santos, Lino ^a   Rodrigues, Alberto ^a   Braga, Pedro ^a   Gonçalves, Manuel ^a   Albuquerque, Aníbal ^a   Gama, Vasco ^a  

^a Vila Nova de Gaia/Espinho Hospital Center   (Portugal)

Author keywords

Aortic stenosis; Cardiac surgery; Percutaneous treatment; Valvuloplasty

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; NITINOL; SODIUM CHLORIDE;

AGED; ANEMIA; AORTA ROOT; AORTA STENOSIS; AORTA SUBVALVULAR STENOSIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTERY DIAMETER; ARTICLE; ASCENDING AORTA; BLEEDING; BLOOD TRANSFUSION; CARDIAC PATIENT; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE SEVERITY; DYSLIPIDEMIA; EMERGENCY SURGERY; FEMALE; FEMORAL ARTERY; FOLLOW UP; FUNCTIONAL STATUS; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART VALVE BIOPROSTHESIS; HEART VENTRICLE THROMBOSIS; HUMAN; HYPERTENSION; HYPOVOLEMIC SHOCK; KIDNEY DISEASE; LOADING DRUG DOSE; LOCAL ANESTHESIA; MALE; MITRAL VALVE REGURGITATION; MULTIPLE ORGAN FAILURE; NEOPLASM; PACEMAKER; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RENAL REPLACEMENT THERAPY; SECOND DEGREE ATRIOVENTRICULAR BLOCK; SEDATION; STROKE; SURGICAL MORTALITY; TRANSIENT ISCHEMIC ATTACK; VASCULAR ACCESS;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; SEVERITY OF ILLNESS INDEX;

EID: 78751686430     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population based study. Lancet 2006;368:1005-11. (Pubitemid 44353666)
2. Astor BC, Kaczmarek RG, Hefflin B, Daley WR. Mortality after aortic valve replacement: results from a nationally representative database. Ann Thorac Surg 2000;70:1939-45. (Pubitemid 32015288)
3. Iung, B, Cachier A, Baron G, et al. Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005;26:2714-20.
4. Bouma BJ, van den Brink RB, Zwinderman K, Cheriex EC, Hamer HH, Lie KI, et al. Which elderly patients with severe aortic stenosis benefit from surgical treatment? An aid to clinical decision making. J Heart Valve Dis. 2004;13:374-81.
5. Alexander KP, Anstrom KJ, Muhlbaier LH, et al. Outcomes of cardiac surgery in patients ?80 years: results from the National Cardiovascular Network. J Am Coll Cardiol 2000;35:731-8.
6. Sharony R, Grossi EA, Saunders PC, et al. Aortic valve replacement in patients with impaired ventricular function. Ann Thorac Surg 2003;75:1808-14. (Pubitemid 36677220)
7. Kvidal P, Bergstrom R, Malm T, Stahle E. Long-term follow-up of morbidity and mortality after aortic valve replacement with a mechanical valve prosthesis. Eur Heart J 2000;21:1099-111.
8. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Lewang OW, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on valvular heart disease. Eur Heart J. 2003;24:1231-43.
9. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.
10. Boudjemline Y, Bonhoeffer P. Steps toward percutaneous aortic valve replacement. Circulation 2002;105:775-8. (Pubitemid 34157385)
11. Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002;106:3006-8
12. Cribier A, Eltchaninoff H, Tron C, et al. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006;47:1214-23.
13. Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006;113:842-50. (Pubitemid 43754305)
14. Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006;114:591-6.
15. Grube E, Laborde JC, Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005;66:465-9. (Pubitemid 41779008)
16. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the Core Valve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006;114:1616-24.
17. Grube E, Schuler G, et al. Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third- Generation Self-Expanding CoreValve Prosthesis. J Am Coll Cardiol 2007;50: 69-76
18. Lamarche Y, Cartier R, Denault AY, Basmadjian A, Berry C, Laborde JC, Bonan R. Implantation of the CoreValve percutaneous aortic valve. Ann Thorac Surg 2007;83:284-287. (Pubitemid 44917866)
19. Kasimir MT, Bialy J, Moidl R, et al. EuroSCORE predicts mid-term outcome after combined valve and coronary bypass surgery. J Heart Valve Dis 2004;13:439-43.
20. Geldorp M, Gameren M, et al. Therapeutic decisions for patients with symptomatic severe aortic stenosis: room for improvement? Eur J Cardiothorac Surg 2009;35 953-959
21. Wendt D, Osswald B et al. STS Score is superior to the EuroSCORE in Determining Mortality in High Risk Patients Undergoing Isolated Aortic Valve Replacement. AnnThorac Sung 2009 August 99 (2) 468-74
22. Berry C, Asgar A, et al. Novel Therapeutic Aspects of Percutaneous Aortic Valve Replacement With the 21F CoreValve RevalvingTM System. Catheter Cardiovasc Interv 2007;70: 610-616
23. Piazza N, Onuma Y, et al. Early and Persistent Intraventricular Conduction Abnormalities and Requirements for Pacemaking After Percutaneous Replacement of the Aortic Valve. J Am Coll Cardiol Intv 2008; 1:310-316